The company maintains a disciplined financial structure with a debt-to-equity ratio of 0.29, though total assets have expanded to $2.6 billion as of 2026Q1, largely driven by aggressive capital investment.
| Total Current Assets | 914.36M | 934.4M | 880.12M | 861.89M | 845.77M | 865.97M | 492.77M | 449.58M |
| Cash & Short-Term Investments | 112.73M | 132.74M | 98.27M | 70.35M | 256.65M | 438.21M | 157.12M | 126.27M |
| Cash Only | 111.67M | 130.54M | 98.27M | 69.6M | 228.74M | 411.04M | 115.6M | 85.39M |
| Short-Term Investments | 1.06M | 2.2M | 0 | 749K | 27.91M | 27.17M | 41.52M | 40.88M |
| Accounts Receivable | 506.66M | 542.17M | 529.87M | 522.48M | 369.48M | 278.42M | 167.25M | 160.58M |
| Days Sales Outstanding | 153.56 | 173.67 | 175.18 | 175.71 | 137.1 | 120.42 | 92.21 | 109.24 |
| Inventory | 294.36M | 268.09M | 245.22M | 255.32M | 213.25M | 148.92M | 139.37M | 131.88M |
| Days Inventory Outstanding | 119.03 | 120.93 | 111.64 | 125.01 | 117.25 | 93.96 | 108.73 | 120.79 |
| Other Current Assets | 606K | -8.6M | 933K | 3.63M | 5.69M | 49K | 28.62M | 30.55M |
| Total Non-Current Assets | 1.67B | 1.61B | 1.45B | 1.21B | 813.92M | 552.87M | 475.2M | 432.6M |
| Property, Plant & Equipment | 1.47B | 1.4B | 1.26B | 1.05B | 660.69M | 415.41M | 339.04M | 306.93M |
| Fixed Asset Turnover | 0.87x | 0.81x | 0.87x | 1.04x | 1.49x | 2.03x | 1.95x | 1.75x |
| Goodwill | 49.98M | 49.96M | 49.98M | 49.98M | 47.24M | 47.24M | 47.24M | 47.24M |
| Intangible Assets | 36.56M | 36.85M | 33.59M | 30.98M | 32.16M | 31.93M | 33.9M | 34.82M |
| Long-Term Investments | 22.6M | 6M | 5.64M | 5.15M | 1.83M | 1.97M | 3.51M | 4.61M |
| Other Non-Current Assets | 893K | 8.6M | 0 | 577K | 2.79M | 447K | 5.96M | 5.9M |
| Total Assets | 2.58B | 2.54B | 2.33B | 2.07B | 1.66B | 1.42B | 967.98M | 882.18M |
| Asset Turnover | 0.49x | 0.45x | 0.47x | 0.52x | 0.59x | 0.59x | 0.68x | 0.61x |
| Asset Growth % | 36.43% | 9.19% | 12.42% | 24.82% | 16.98% | 46.58% | 9.73% | - |
| Total Current Liabilities | 560.27M | 535.57M | 477.47M | 574.39M | 462.5M | 338.62M | 316.18M | 262.94M |
| Accounts Payable | 254.36M | 263.19M | 231.02M | 277.81M | 239.18M | 164.79M | 118.74M | 95.05M |
| Days Payables Outstanding | 101.96 | 118.72 | 105.18 | 136.03 | 131.5 | 103.97 | 92.63 | 87.06 |
| Short-Term Debt | 119.32M | 121.69M | 106.84M | 135.6M | 64.63M | 37.17M | 63.45M | 65.35M |
| Deferred Revenue (Current) | 179.21M | 43.78M | 44.67M | 58.8M | 53.89M | 50.61M | 56.9M | 50.43M |
| Other Current Liabilities | 91.92M | 106.91M | 15.45M | 11.15M | -3.73M | 5.33M | 17.49M | 10.83M |
| Current Ratio | 1.63x | 1.74x | 1.84x | 1.50x | 1.83x | 2.56x | 1.56x | 1.71x |
| Quick Ratio | 1.11x | 1.24x | 1.33x | 1.06x | 1.37x | 2.12x | 1.12x | 1.21x |
| Cash Conversion Cycle | 170.63 | 175.88 | 181.64 | 164.69 | 122.84 | 110.41 | 108.31 | 142.97 |
| Total Non-Current Liabilities | 492.73M | 521.38M | 446.96M | 364.54M | 201.29M | 238.56M | 341.66M | 353.8M |
| Long-Term Debt | 312.57M | 337.64M | 305.23M | 242.05M | 133.75M | 183.99M | 273.94M | 290.88M |
| Capital Lease Obligations | 39.94M | 9.37M | 11.81M | 13.1M | 14.66M | 17.57M | 20.19M | 21.26M |
| Deferred Tax Liabilities | 54.1M | 13.29M | 12.56M | 9.62M | 20.95M | 19.11M | 11.62M | 0 |
| Other Non-Current Liabilities | 11.34M | 62.07M | 73.32M | 60.35M | 31.93M | 17.89M | 35.92M | 41.66M |
| Total Liabilities | 1.05B | 1.06B | 924.43M | 938.93M | 663.79M | 577.18M | 657.84M | 616.74M |
| Total Debt | 448.52M | 470.7M | 428.97M | 396.59M | 218.37M | 244.29M | 363.01M | 375.67M |
| Net Debt | 336.85M | 340.16M | 330.7M | 326.99M | -10.37M | -166.75M | 247.41M | 290.28M |
| Debt / Equity | 0.29x | 0.32x | 0.31x | 0.35x | 0.22x | 0.29x | 1.17x | 1.42x |
| Debt / EBITDA | 1.54x | 1.76x | 1.77x | 1.42x | 0.85x | 1.12x | 2.31x | 3.46x |
| Net Debt / EBITDA | 1.16x | 1.27x | 1.37x | 1.17x | -0.04x | -0.76x | 1.57x | 2.68x |
| Interest Coverage | 21.53x | 8.40x | 24.35x | 44.93x | 48.67x | 35.01x | 15.06x | 11.38x |
| Total Equity | 1.53B | 1.49B | 1.4B | 1.13B | 995.91M | 841.66M | 310.14M | 265.44M |
| Equity Growth % | 28.19% | 5.8% | 23.99% | 13.73% | 18.33% | 171.38% | 16.84% | - |
| Book Value per Share | 5.61 | 5.44 | 5.15 | 4.27 | 3.76 | 3.18 | 1.17 | 1.00 |
| Total Shareholders' Equity | 1.53B | 1.49B | 1.4B | 1.13B | 996.13M | 842.07M | 310.5M | 265.49M |
| Common Stock | 22.23M | 22.22M | 22.23M | 21.7M | 21.7M | 21.7M | 20M | 20M |
| Retained Earnings | 1.02B | 876.41M | 863.44M | 757.86M | 623.35M | 0 | 0 | 0 |
| Treasury Stock | -27.08M | -27.07M | -27.15M | -27.23M | -27.74M | 0 | 0 | 0 |
| Accumulated OCI | -43.54M | 54.95M | -13.75M | -9.11M | -10.49M | 686.05M | 211.98M | 206.29M |
| Minority Interest | 36K | 37.98K | 46K | 115K | -220K | -415K | -355K | -50K |
Capital expenditure intensity
Based on reported financial statements, Stevanato's total assets have grown from $2.1 billion in 2023Q4 to $2.6 billion in 2026Q1, while equity has remained relatively constrained, suggesting that the company is increasingly relying on external financing to fund its aggressive global manufacturing footprint expansion.
The steady climb in total assets reflects the ongoing capitalization of new facilities, yet the slower growth in equity indicates that the firm is not yet generating sufficient retained earnings to self-fund this capital-intensive phase. Investors should monitor whether this asset-heavy trajectory eventually yields the expected margin expansion or if it leads to diminishing returns on invested capital.
As reported in recent SEC filings, Stevanato maintains a disciplined debt-to-equity ratio of 0.29 as of 2026Q1, which indicates that management has successfully avoided over-leveraging the balance sheet despite the significant capital requirements associated with building out international production capacity for high-value drug delivery solutions.
The current debt profile appears manageable, providing the company with a necessary buffer against potential volatility in energy costs or project-based revenue delays. This conservative stance suggests that the firm retains sufficient financial flexibility to navigate cyclical downturns without facing immediate refinancing risks or liquidity constraints.
According to the provided balance sheet data, net property, plant, and equipment (PPE) has surged to $1.5 billion by 2026Q1, representing the vast majority of the company's asset base and underscoring the firm's transition into a highly capital-intensive industrial operator within the biopharmaceutical supply chain.
The concentration of value in physical infrastructure highlights the company's reliance on specialized manufacturing capabilities to maintain its competitive moat. While this asset-heavy model creates high barriers to entry, it also necessitates consistent, high-volume utilization to justify the depreciation burden and maintain long-term profitability.
Based on the company's reported figures, the current ratio has fluctuated between 1.50 and 1.92 over the last ten quarters, indicating that Stevanato maintains an adequate liquidity position to meet its short-term obligations despite the lumpy nature of its engineering project cash flows and ongoing capital investments.
The ability to sustain a current ratio above 1.50 suggests that management is effectively balancing working capital needs with the cash demands of its global expansion. However, the variability in cash balances warrants continued observation to ensure that the company remains insulated from unexpected operational disruptions or supply chain shocks.
Quick answers to the most common questions about buying STVN stock.
As of 2025, Stevanato Group S.p.A. (STVN) had total assets of $2.54B including $934.4M in current assets.
Stevanato Group S.p.A. (STVN) carries total debt of $470.7M, offset by $132.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Stevanato Group S.p.A. (STVN) has total shareholders' equity (book value) of $1.49B ($5.44 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Stevanato Group S.p.A. (STVN) reported a current ratio of 1.74x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.